Your browser doesn't support javascript.
loading
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children.
McFarland, Elizabeth J; Karron, Ruth A; Muresan, Petronella; Cunningham, Coleen K; Perlowski, Charlotte; Libous, Jennifer; Oliva, Jennifer; Jean-Philippe, Patrick; Moye, Jack; Schappell, Elizabeth; Barr, Emily; Rexroad, Vivian; Fearn, Laura; Cielo, Mikhaela; Wiznia, Andrew; Deville, Jaime G; Yang, Lijuan; Luongo, Cindy; Collins, Peter L; Buchholz, Ursula J.
Afiliación
  • McFarland EJ; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, Colorado, USA.
  • Karron RA; Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Muresan P; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health/Frontier Science Foundation, Boston, Massachusetts, USA.
  • Cunningham CK; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
  • Perlowski C; FHI 360, Durham, North Carolina, USA.
  • Libous J; FHI 360, Durham, North Carolina, USA.
  • Oliva J; Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Jean-Philippe P; Maternal, Adolescent and Pediatric Research Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Moye J; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
  • Schappell E; Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Barr E; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, Colorado, USA.
  • Rexroad V; Investigational Drug Service Pharmacy, Johns Hopkins Hospital, Baltimore, Maryland, USA.
  • Fearn L; Department of Pediatrics, Northwestern University Medical School and Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Cielo M; Division of Infectious Diseases, Maternal Child & Adolescent Center, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
  • Wiznia A; Department of Pediatrics, Albert Einstein College of Medicine and Jacobi Medical Center, Bronx, New York, USA.
  • Deville JG; David Geffen School of Medicine at University of California Los Angeles, California, USA.
  • Yang L; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Luongo C; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Collins PL; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Buchholz UJ; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
J Infect Dis ; 221(12): 2050-2059, 2020 06 11.
Article en En | MEDLINE | ID: mdl-32006006
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Virales / Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio / Anticuerpos Antivirales Tipo de estudio: Clinical_trials Límite: Adolescent / Child / Humans Idioma: En Revista: J Infect Dis Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Virales / Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio / Anticuerpos Antivirales Tipo de estudio: Clinical_trials Límite: Adolescent / Child / Humans Idioma: En Revista: J Infect Dis Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos